Inventor
ELLISON MURIELLE MARIE
US13 patents
⚠️ This page may combine multiple inventors who share the name “ELLISON MURIELLE MARIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
7 patentsUS8034770B2Oct 11, 2011
FGF21 polypeptides comprising two or more mutations
AMGEN INC63 citations99
US8361963B2Jan 29, 2013
Uses of FGF21 polypeptides comprising two or more mutations
AMGEN INC64 citations98
US9273106B2Mar 1, 2016
FGF mutants with reduced proteolysis and aggregation
AMGEN INC9 citations92
US11072640B2Jul 27, 2021
Methods of treating non-alcoholic steatohepatitis using FGF21 mutants
AMGEN INC3 citations84
US10011642B2Jul 3, 2018
Methods of treating of diabetes and obesity using FGF21 mutants
AMGEN INC4 citations84
US9493530B2Nov 15, 2016
FGF21 mutants comprising a mutation at position 98, 171 and/or 180
AMGEN INC10 citations84
US11840558B2Dec 12, 2023
Methods of treating non-alcoholic steatohepatitis using FGF21 mutants
AMGEN INC0 citations62
BELOUSKI EDWARD JOHN
6 patentsUS8835385B2Sep 16, 2014
FGF21 polypeptides comprising two or more mutations and uses thereof
BELOUSKI EDWARD JOHN48 citations97
US8795985B2Aug 5, 2014
FGF 21 polypeptides comprising two or more mutations and uses thereof
BELOUSKI EDWARD JOHN48 citations97
US8642546B2Feb 4, 2014
FGF21 mutant fusion polypeptides and uses thereof
BELOUSKI EDWARD JOHN64 citations97
US8618053B2Dec 31, 2013
FGF21 mutants multimers and uses thereof
BELOUSKI EDWARD JOHN45 citations97
US8410051B2Apr 2, 2013
FGF21 mutants and uses thereof
BELOUSKI EDWARD JOHN63 citations97
US8188040B2May 29, 2012
FGF21 mutants and uses thereof
BELOUSKI EDWARD JOHN59 citations97